andrew hiller bpc 157 Peptides for Dummies 2 Attachment 4 - Table 4

GLOW is a research blend that unites three widely studied peptides: GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg) in a single vial

doi: 10.1016/j.cbpa.2015.11.007

Instead, each parent has a single non-working gene for MMA

No FDA status Not FDA-approved as a drug These compounds are not interchangeable

By 48 weeks, significant average weight loss was seen at all maintenance doses: With longer treatment lasting up to 68 weeks, weight loss continued, particularly at higher doses: 12mg: average weight loss of up to 28.7% of body weight This longer-term data shows that weight loss with retatrutide can continue beyond one year, rather than plateauing early, especially at higher maintenance doses